At Retrophin, we come to work every day to do something extraordinary that can make a difference in the lives of people living with rare disease, especially glomerular disorders such as focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). We are committed to collaborating with the rare disease community to identify, develop and deliver life-changing therapies as soon as possible. Through our portfolio of approved products and our promising pipeline in nephrology and hepatology, we strive to help people achieve the best possible outcomes today and tomorrow.